Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Cornea Editor Clara Chan, MD, described how innovation, progression, and disruption keep the field evolving and introduced the new Cornea Editor, Julie Schallhorn, MD.
For the last decade, interferon alpha-2b was the preferred pharmacologic therapy for ocular surface squamous neoplasia (OSSN) in the U.S. However, with the pandemic, the makers of interferon transitioned its use for treatment of COVID-19 patients instead. This article covers other OSSN treatment options.
➤ FDA accepts NDA for pupil dilation spray ➤ NDA for new glaucoma drug accepted ➤ PMA application submitted to FDA for new IOL ➤ Data report: 12-month efficacy seen from single mechanical MGD treatment ➤ Acquisition of company developing drugs for rare ophthalmic diseases ➤ ASCRS news and events
When treating endothelial dysfunction, surgeons have several options. The current standard of care is endothelial keratoplasty, DSAEK and DMEK. One new therapy that has been getting a lot of attention is corneal endothelial cell therapy, and there has been significant progress in the last 18 months.
The push for widespread COVID-19 vaccination has renewed the focus on the side effects that vaccines may have. It’s an especially unique situation due to the distinct timeframe for this mass vaccination campaign. Two experts spoke about potential ocular impacts of the vaccine and what physicians should look for.
➤ NDA submitted for new, topical dry eye disease treatment ➤ IND submitted for persistent corneal epithelial defect treatment ➤ IND filed for dry eye disease treatment ➤ Study: Investigational topical drop reduces inflammation in anterior uveitis cases ➤ Alcon completes acquisition of Aerie ➤ ASCRS news and events
During a session at the 2022 AAO Annual Meeting, Christopher Rapuano, MD, and Sonia Yoo, MD, debated the best way to surgically manage recurrent corneal erosions. The audience was polled ahead of the presentations, with 65% indicating that they thought epithelial debridement with diamond burr polishing of Bowman’s layer is better; 25% said that PTK is better.
➤ NDA submitted to FDA for once-daily glaucoma drop ➤ Positive Phase 3 data for novel preservative-free latanoprost delivery method ➤ Phase 4 DME safety study reduces need for treatments ➤ New data from Phase 3 trial for investigational Acanthamoeba keratitis treatment ➤ New findings on visual potential for adults with Leber congenital amaurosis ➤ ASCRS news and events
Corneal imaging for IOL planning is vital, but what instruments to use and what the measurements from these different instruments inform varies. EyeWorld spoke with two physicians to get their thoughts on corneal imaging as part of the preop planning process.
Aqueous tear deficient dry eye and evaporative dry eye—distinguishing between the two, knowing when both are at play, and treatment options are of growing importance as more patients are identified with some form of dry eye and as certain refractive procedures depend on a healthy ocular surface.
Get the latest ophthalmology news delivered to your inbox every Friday.